FeedsFarm.com > Ambrilia Biopharma Inc.: Ambrilia Announces European Licensing Partnership with TEVA for its Lead Oncology Product, Octreotide

Source:

Market Wire - Pharmaceuticals and Biotech

Language:

English

Tag/Category:

amb

Domain:

img.marketwire.com

More feeds from marketwire.com:

• Market Wire - Computers and Software
• Market Wire - Conference Calls
• Market Wire - Education and Training
• Market Wire - Energy and Utilities
• Market Wire - Environment
• Market Wire - Financial Services
• Market Wire - Food and Beverage
• Market Wire - Management Changes
• Market Wire - Retail
• Market Wire - Telecom

Search marketwire.com:

Ambrilia Biopharma Inc.: Ambrilia Announces European Licensing Partnership with TEVA for its Lead Oncology Product, Octreotide

16th Nov 2006, 08:23 GMT

MONTREAL, QUEBEC (MARKET WIRE)

Latest news from Market Wire - Pharmaceuticals and Biotech:

• Qiagen N.V.: QIAGEN Introduces Novel Technology for Customized RNAi Assay Products
• IBEX TECHNOLOGIES INC.: IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
• Daiichi Sankyo, Inc.: First Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits
• Daiichi Sankyo, Inc.: WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
• Targeted Genetics Corporation: Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting
• Crucell N.V.: Crucell Announces Third Quarter 2006 Results
• Acambis PLC: Acambis PLC announces Update on US MVA procurement
• SkyePharma PLC: SkyePharma PLC announces Board Appointment
• Base Technologies, Inc.: Base Technologies Award of Air Force Surgeon General Contract Continues Rapid Growth Trend
• Eugene Science, Inc.: Eugene Science Signs Major Distribution Agreement With RexGene Biotech